Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Nebbioso

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
Frontiers in Pharmacology|February 10, 2012
Sirtuins and disease: the road aheadVincenzo Carafa, Angela Nebbioso, Lucia Altucci
Recent Patents on Anti-Cancer Drug Discovery|November 30, 2010
Histone deacetylase inhibitors: recent insights from basic to clinical knowledge & patenting of anti-cancer actionsVincenzo Carafa, Angela Nebbioso, Lucia Altucci
Epigenetics|December 3, 2019
DOT1L: a key target in normal chromatin remodelling and in mixed-lineage leukaemia treatmentFederica Sarno, Angela Nebbioso, Lucia Altucci
Frontiers in Pharmacology|February 15, 2019
Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant PhenotypeVincenzo Carafa, Lucia Altucci, Angela Nebbioso
Expert Opinion on Therapeutic Patents|October 26, 2012
Histone deacetylase inhibitors: a patent review (2009 - 2011)Vincenzo Carafa, Marco Miceli, Lucia Altucci, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|August 21, 2014
Natural compounds in epigenetics: a current viewMarco Miceli, Paola Bontempo, Angela Nebbioso, et al.
Frontiers in Pharmacology|August 28, 2020
SIRT1 Activation by Natural Phytochemicals: An OverviewConcetta Iside, Marika Scafuro, Angela Nebbioso, et al.
Marine Drugs|January 20, 2023
Recent Advancement in Anticancer Compounds from Marine Organisms: Approval, Use and Bioinformatic Approaches to Predict New TargetsGiovanna Santaniello, Angela Nebbioso, Lucia Altucci, et al.
Cell Cycle (Georgetown, Tex.)|June 23, 2005
TRAIL: at the center of drugable anti-tumor pathwaysNicole Clarke, Angela Nebbioso, Lucia Altucci, et al.
Molecular Oncology|October 30, 2012
Trials with 'epigenetic' drugs: an updateAngela Nebbioso, Vincenzo Carafa, Rosaria Benedetti, et al.
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
Frontiers in Pharmacology|February 10, 2012
Sirtuins and disease: the road aheadVincenzo Carafa, Angela Nebbioso, Lucia Altucci
Recent Patents on Anti-Cancer Drug Discovery|November 30, 2010
Histone deacetylase inhibitors: recent insights from basic to clinical knowledge & patenting of anti-cancer actionsVincenzo Carafa, Angela Nebbioso, Lucia Altucci
Epigenetics|December 3, 2019
DOT1L: a key target in normal chromatin remodelling and in mixed-lineage leukaemia treatmentFederica Sarno, Angela Nebbioso, Lucia Altucci
Frontiers in Pharmacology|February 15, 2019
Dual Tumor Suppressor and Tumor Promoter Action of Sirtuins in Determining Malignant PhenotypeVincenzo Carafa, Lucia Altucci, Angela Nebbioso
Expert Opinion on Therapeutic Patents|October 26, 2012
Histone deacetylase inhibitors: a patent review (2009 - 2011)Vincenzo Carafa, Marco Miceli, Lucia Altucci, et al.
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|August 21, 2014
Natural compounds in epigenetics: a current viewMarco Miceli, Paola Bontempo, Angela Nebbioso, et al.
Frontiers in Pharmacology|August 28, 2020
SIRT1 Activation by Natural Phytochemicals: An OverviewConcetta Iside, Marika Scafuro, Angela Nebbioso, et al.
Marine Drugs|January 20, 2023
Recent Advancement in Anticancer Compounds from Marine Organisms: Approval, Use and Bioinformatic Approaches to Predict New TargetsGiovanna Santaniello, Angela Nebbioso, Lucia Altucci, et al.
Cell Cycle (Georgetown, Tex.)|June 23, 2005
TRAIL: at the center of drugable anti-tumor pathwaysNicole Clarke, Angela Nebbioso, Lucia Altucci, et al.
Molecular Oncology|October 30, 2012
Trials with 'epigenetic' drugs: an updateAngela Nebbioso, Vincenzo Carafa, Rosaria Benedetti, et al.
Pageof 15